However, more recent studies have shown that not all heterozygous carriers of COL4A3 and COL4A4 variants had a benign course, with some individuals presenting with progressive hematuria and proteinuria, FSGS, hypertension, and KF [6, 9, 32–39]. This evidence concerns the gene COL4A4 and focal segmental glomerulosclerosis.